The translational biology of remyelination: past, present, and future.

@article{Franklin2014TheTB,
  title={The translational biology of remyelination: past, present, and future.},
  author={Robin J. M. Franklin and Vittorio Gallo},
  journal={Glia},
  year={2014},
  volume={62 11},
  pages={1905-15}
}
Amongst neurological diseases, multiple sclerosis (MS) presents an attractive target for regenerative medicine. This is because the primary pathology, the loss of myelin-forming oligodendrocytes, can be followed by a spontaneous and efficient regenerative process called remyelination. While cell transplantation approaches have been explored as a means of replacing lost oligodendrocytes, more recently therapeutic approaches that target the endogenous regenerative process have been favored. This… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS